As we found that miR-222 selectively inhibits endothelial ICAM-1 expression, which contributes to vascular inflammation and atherosclerosis, we finally explored whether miR-222 levels are altered in patients with CAD (CAD). This evidence concerns the gene ICAM1 and atherosclerosis.